The American Journal of Surgery 2009-01-01

Tautomycin suppresses growth and neuroendocrine hormone markers in carcinoid cells through activation of the Raf-1 pathway

Scott N. Pinchot, Joel T. Adler, Yinggang Luo, Jianhua Ju, Wenli Li, Ben Shen, Muthusamy Kunnimalaiyaan, Herbert Chen

Index: Am. J. Surg. 197(3) , 313-9, (2009)

Full Text: HTML

Abstract

Background Carcinoids are neuroendocrine (NE) tumors with limited treatment options. Raf-1 pathway activation has been shown to suppress hormone production in carcinoid cells. We investigated a novel treatment for carcinoid cell growth based on pharmacologic Raf-1 activation using the compound tautomycin (TTY).

Related Compounds

  • Tautomycin

Related Articles:

Characterization of the tautomycetin biosynthetic gene cluster from Streptomyces griseochromogenes provides new insight into dialkylmaleic anhydride biosynthesis.

2009-03-27

[J. Nat. Prod. 72(3) , 450-9, (2009)]

The bifunctional glyceryl transferase/phosphatase OzmB belonging to the HAD superfamily that diverts 1,3-bisphosphoglycerate into polyketide biosynthesis.

2006-08-16

[J. Am. Chem. Soc. 128(32) , 10386-7, (2006)]

PR55 alpha, a regulatory subunit of PP2A, specifically regulates PP2A-mediated beta-catenin dephosphorylation.

2009-08-21

[J. Biol. Chem. 284 , 22649 - 22656, (2009)]

Tautomycin's interactions with protein phosphatase 1.

2010-03-01

[Chem. Asian J. 5(3) , 410-20, (2010)]

Functional characterization of ttmM unveils new tautomycin analogs and insight into tautomycin biosynthesis and activity.

2009-04-02

[Org. Lett. 11(7) , 1639-42, (2009)]

More Articles...